The role of aggregate formation in the pathophysiology of Huntington’s disease (HD) remains uncertain. However, the temporal appearance of aggregates tends to correlate with the onset of symptoms and the numbers of neuropil aggregates correlate with the progression of clinical disease. Using highly sensitive immunohistochemical methods we have detected the appearance of diffuse aggregates during embryonic development in the R6/2 and YAC128 mouse models of HD. These are initially seen in developing axonal tracts and appear to spread throughout the cerebrum in the early neonate.
MacDonaldME, AmbroseCM, DuyaoMP, MyersRH, LinC, SrinidhiL, BarnesG, et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. The Huntington’s Disease Collaborative Research Group Cell. 1993;72(6):971–83.
2.
LangbehnDR, BrinkmanRR, FalushD, PaulsenJS, HaydenMR. International Huntington’s Disease Collaborative Group. A new model for prediction of the age of onset and penetrance for Huntington’s disease based on CAG length. Clin Genet. 2004;65(4):267–77.
3.
LunkesA, LindenbergKS, Ben-HaïemL, WeberC, DevysD, LandwehrmeyerGB, et al. Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions. Mol Cell. 2002;(2):259–69.
4.
GutekunstCA, LiSH, YiH, MulroyJS, KuemmerleS, JonesR, RyeD, et al. Nuclear and neuropil aggregates inHuntington’s disease: Relationship to neuropathology. J Neurosci. 1999;19(7):2522–34.
5.
NguyenHP, KobbeP, RahneH, WörpelT, JägerB, StephanM, et al. Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington’s disease. Hum Mol Genet. 2006;15(21):3177–94.
6.
ArrasateM, MitraS, SchweitzerES, SegalMR, FinkbeinerS. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature. 2004;431(7010):805–10.
7.
MillerJ, ArrasateM, BrooksE, LibeuCP, LegleiterJ, HattersD, et al. Identifying polyglutamine protein species in situ that best predict neurodegeneration. Nat Chem Biol. 2011;7(12):925–34.
8.
TanZ, DaiW, van ErpTG, OvermanJ, DemuroA, DigmanMA, et al. Huntington’s disease cerebrospinal fluid seeds aggregation of mutant huntingtin. Mol Psychiatry. 2015;(11):1286–93.
9.
PearceMM, SpartzEJ, HongW, LuoL, KopitoRR. Prion-like transmission of neuronal huntingtin aggregates to phagocytic glia in the Drosophila brain. Nat Commun. 2015;6:6768.
10.
SathasivamK, WoodmanB, MahalA, BertauxF, WankerEE, ShimaDT, et al. Centrosome disorganization in fibroblast cultures derived from R6/2 Huntington’s disease (HD) transgenic mice and HD patients. Hum Mol Genet. 2001;10(21):2425–35.
11.
Van RaamsdonkJM, MurphyZ, SlowEJ, LeavittBR, HaydenMR. Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease. Hum Mol Genet. 2005;14(24):3823–35.
12.
BrooksSP, JonesL, DunnettSB. Comparative analysis of pathology and behavioural phenotypes in mouse models of Huntington’s disease. Brain Res Bull. 2012;88(2-3):81–93.
13.
SlowEJ, GrahamRK, OsmandAP, DevonRS, LuG, et al. Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions. Proc Natl Acad Sci U S A. 2005;102(32):11402–7.
14.
OliveiraAO, OsmandA, OuteiroTF, MuchowskiPJ, FinkbeinerS. αB-Crystallin overexpression in astrocytes modulates the phenotype of the BACHD mouse model of Huntington’s disease. Hum Mol Genet. 2016;25(9):1677–89.
15.
SathasivamK, NeuederA, GipsonTA, LandlesC, BenjaminAC, BondulichMK, et al. Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease. Proc Natl Acad Sci U S A. 2013;110(6):2366–70.
16.
Bañez-CoronelM, AyhanF, TarabochiaAD, ZuT, PerezBA, TusiSK, et al. RAN translation in Huntington disease. Neuron. 2015;88(4):667–77.
17.
NopoulosPC, AylwardEH, RossCA, MillsJA, LangbehnDR, JohnsonHJ, et al. Smaller intracranial volume in prodromal Huntington’s disease: Evidence for abnormal neurodevelopment. Brain. 2011;134(Pt 1):137–42.
18.
HumbertS. Is Huntington disease a developmental disorder?EMBO Rep2010;11(12):899.
19.
KerschbamerE, BiagioliM. Huntington’s disease as neurodevelopmental disorder: Altered chromatin regulation, coding, and non-coding RNA transcription. Front Neurosci. 2015;9, 509. http://doi.org/10.3389/fnins.2015.00509
20.
MoleroAE, Arteaga-BrachoEE, ChenCH, GulinelloM, WinchesterML, PichamoorthyN, et al. Selective expression of mutant huntingtin during development recapitulates characteristic features of Huntington’s disease. Proc Natl Acad Sci U S A. 2016;113(20):5736–41.
